ANA BY ELISA (Antinuclear Antibody) at Ayzal Lab

ANA BY ELISA (Antinuclear Antibody) at Ayzal Lab

The Antinuclear Antibody (ANA) test by Enzyme-Linked Immunosorbent Assay (ELISA) is a highly sensitive laboratory investigation utilized to detect autoantibodies in the blood. Autoantibodies are proteins produced by the immune system that mistakenly target the body’s own cellular components, specifically the nucleus of healthy cells. Under normal physiological conditions, the immune system generates antibodies to defend against foreign pathogens such as viruses and bacteria. However, in autoimmune disorders, this self-tolerance is compromised, leading to the production of antinuclear antibodies. Identifying these autoantibodies is a critical step in diagnosing systemic autoimmune diseases and guiding appropriate clinical management.

At Ayzal Lab, located in Lahore, Pakistan, the ANA by ELISA test is performed using advanced diagnostic equipment and standardized laboratory protocols. The ELISA technique utilizes specific antigen-coated microtiter plates to bind antinuclear antibodies present in the patient’s serum. Once bound, these antibodies are detected using enzyme-labeled conjugates that produce a colorimetric reaction, the intensity of which is directly proportional to the concentration of ANA in the sample. This quantitative and semi-quantitative approach offers high sensitivity, making it an excellent screening tool for patients presenting with clinical symptoms suggestive of connective tissue disorders or systemic autoimmune conditions.

The clinical importance of the ANA by ELISA test lies in its high negative predictive value. A negative result strongly suggests that an active systemic autoimmune process, such as Systemic Lupus Erythematosus (SLE), is highly unlikely. Conversely, a positive result indicates the presence of antinuclear antibodies and warrants further clinical evaluation, including specific sub-antibody testing (such as anti-dsDNA, anti-Sm, or anti-SSA/SSB panels) and detailed clinical correlation. By providing reliable and precise screening, Ayzal Lab assists rheumatologists, internists, and general practitioners in Lahore in establishing accurate diagnoses, monitoring disease progression, and tailoring personalized treatment strategies for patients experiencing complex autoimmune symptoms.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest accuracy of your ANA by ELISA test at Ayzal Lab, patients are advised to adhere to the following preparation guidelines:

• Fasting Requirements: Routine fasting is generally not required for the ANA by ELISA test. Patients may eat and drink normally prior to sample collection unless instructed otherwise by their referring physician.
• Medication Disclosure: It is essential to inform the laboratory staff and your physician of all medications, supplements, and herbal remedies you are currently taking. Certain drugs, such as hydralazine, procainamide, and isoniazid, can induce the production of antinuclear antibodies, leading to drug-induced lupus-like syndromes.
• Hydration: Staying well-hydrated by drinking adequate amounts of water prior to the blood draw is highly recommended, as it makes the veins more accessible and facilitates a smoother venipuncture process.
• Stress and Illness: Inform the laboratory if you are experiencing an acute infection or severe physical stress, as these temporary physiological states can occasionally influence immune markers.

During the Procedure

The ANA by ELISA test is a straightforward blood test (venipuncture) performed by the experienced phlebotomists at Ayzal Lab. The entire procedure is designed to be quick, safe, and minimally invasive:

• Patient Positioning: You will be asked to sit comfortably in a specialized phlebotomy chair. The phlebotomist will ask you to extend your arm, resting it on a stable support.
• Site Selection and Cleansing: The phlebotomist will inspect your arm, typically the antecubital fossa (the crease of the elbow), to locate a suitable and prominent vein. Once selected, the area is thoroughly cleansed with an antiseptic swab (isopropyl alcohol) to prevent contamination.
• Tourniquet Application: A sterile elastic tourniquet is tied around your upper arm to temporarily restrict blood flow, causing the veins to swell and become more visible and accessible.
• Venipuncture: A sterile, single-use needle is gently inserted into the selected vein. You may feel a brief pinch or stinging sensation at the moment of insertion. Blood is drawn directly into a vacuum collection tube containing a clot activator and gel for serum separation (SST tube).
• Needle Removal and Pressure: Once the required volume of blood is collected, the tourniquet is released, and the needle is carefully withdrawn. The phlebotomist will immediately apply a sterile cotton ball or gauze pad to the puncture site, instructing you to apply firm pressure for a few minutes to stop any minor bleeding.
• Bandaging: A small adhesive bandage is applied over the site. You will be advised to keep the bandage on for at least an hour and avoid heavy lifting with that arm for the remainder of the day.
• Safety and Comfort: The entire sample collection process takes less than five minutes. All materials used are sterile and disposable, ensuring zero risk of cross-contamination.

When is an ANA BY ELISA Performed?

Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus (SLE) is a chronic, multi-system autoimmune disease that can affect the skin, joints, kidneys, brain, and other vital organs. Physicians frequently order the ANA by ELISA test when a patient presents with classic symptoms of SLE, such as a malar (butterfly) rash across the cheeks and nose, photosensitivity, unexplained joint pain, prolonged fatigue, and recurrent low-grade fevers. Because over 95% of patients with active SLE test positive for ANA, this test serves as an essential initial screening tool. A positive result prompts further specific testing to confirm the diagnosis and assess organ involvement.

Sjögren’s Syndrome

Sjögren’s Syndrome is an autoimmune disorder characterized by the destruction of exocrine glands, primarily leading to severe dryness of the eyes (keratoconjunctivitis sicca) and mouth (xerostomia). Patients may also experience joint pain, skin dryness, and chronic fatigue. When these symptoms are present, clinicians utilize the ANA by ELISA test as part of the diagnostic workup. A positive ANA result, often followed by testing for specific autoantibodies like anti-SSA (Ro) and anti-SSB (La), helps differentiate Sjögren’s Syndrome from other causes of dry eyes and mouth, enabling early therapeutic intervention.

Systemic Sclerosis (Scleroderma)

Systemic Sclerosis, or Scleroderma, is a rare connective tissue disease characterized by abnormal collagen deposition, leading to thickening and hardening of the skin and potential damage to internal organs such as the lungs, heart, and digestive tract. Early signs include Raynaud’s phenomenon (color changes in fingers and toes in response to cold), joint stiffness, and skin tightening. The ANA by ELISA test is highly sensitive for systemic sclerosis, with positive results found in the vast majority of affected individuals. Identifying ANA early helps clinicians monitor for internal organ involvement and initiate disease-modifying therapies.

Polymyositis and Dermatomyositis

Polymyositis and Dermatomyositis are inflammatory myopathies characterized by progressive muscle weakness, particularly in the proximal muscles (shoulders, upper arms, hips, and thighs). Dermatomyositis also presents with distinctive skin rashes, including a heliotrope rash around the eyes and Gottron’s papules over the knuckles. When a patient exhibits unexplained muscle weakness or characteristic skin lesions, physicians request the ANA by ELISA test. A positive result supports the diagnosis of an autoimmune-mediated muscle disease and guides the clinical team toward muscle enzyme tests and electromyography.

Mixed Connective Tissue Disease (MCTD)

Mixed Connective Tissue Disease (MCTD) is an overlap syndrome that combines clinical features of SLE, systemic sclerosis, and polymyositis. Patients may experience a combination of joint pain, Raynaud’s phenomenon, swollen hands, and muscle inflammation. Because the clinical presentation can be highly variable and confusing, the ANA by ELISA test is performed as an essential baseline screening. A positive ANA, particularly when associated with high titers of anti-U1 ribonucleoprotein (RNP) antibodies, is a defining diagnostic criterion for MCTD, helping physicians establish a clear clinical pathway.

What Does an ANA BY ELISA Detect?

The ANA by ELISA test detects the presence and relative concentration of autoantibodies directed against various nuclear and cytoplasmic antigens. Specifically, this assay can identify reactivity against:

• Double-Stranded DNA (dsDNA): Highly specific for Systemic Lupus Erythematosus (SLE) and associated with lupus nephritis.
• Smith Antigen (Sm): An essential diagnostic marker highly specific for SLE.
• Sjögren’s Syndrome Antigens A and B (SSA/Ro and SSB/La): Commonly associated with Sjögren’s syndrome and cutaneous lupus.
• U1 Ribonucleoprotein (U1-RNP): The hallmark autoantibody for Mixed Connective Tissue Disease (MCTD).
• Scl-70 (Topoisomerase I): Strongly associated with diffuse cutaneous systemic sclerosis.
• Centromere Proteins (CENP): Associated with limited cutaneous systemic sclerosis (CREST syndrome).
• Jo-1 (Histidyl-tRNA Synthetase): Associated with polymyositis and antisynthetase syndrome.
• Histones: Frequently detected in drug-induced lupus erythematosus.
• Ribosomal P Protein: Associated with neuropsychiatric manifestations of SLE.
• RNA Polymerase III: Associated with severe systemic sclerosis and renal crisis risk.
• PM-Scl: Found in patients with polymyositis-scleroderma overlap syndrome.
• Mi-2: Highly specific for dermatomyositis.
• Fibrillarin (U3 RNP): Associated with systemic sclerosis and pulmonary hypertension.
• PCNA (Proliferating Cell Nuclear Antigen): A rare but highly specific marker for SLE.
• Ku Antigen: Associated with overlap syndromes involving polymyositis and systemic sclerosis.
• Ro-52: Often co-detected with SSA-60, associated with various autoimmune diseases and congenital heart block.
• Nucleosomes: Important marker in the pathogenesis of SLE and lupus nephritis.
• Sm/RNP Complex: Commonly evaluated in systemic autoimmune rheumatic diseases.
• Cytoplasmic Antigens: Can occasionally cause positive ANA reactions, indicating non-nuclear autoimmune activity.
• Low-Titer Non-Specific Antibodies: Can be detected in healthy individuals, elderly patients, or during chronic infections.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for patient care and clinical decision-making. The ANA by ELISA test is processed in our specialized immunology department using automated systems that ensure both speed and precision. Generally, the test results are verified and available within 24 to 48 hours from the time of sample collection.

Once the report is finalized by our consultant pathologist, patients receive an automated SMS notification on their registered mobile number. Reports can be accessed and downloaded directly from the official Ayzal Lab online portal or mobile application, eliminating the need for an extra visit to the lab. Physical copies of the reports can also be collected from our main collection center in Lahore during working hours.

ANA BY ELISA Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
ANA Screening Index (ELISA)	Negative (typically < 1.0 Ratio or within reference range)	Positive (typically >= 1.0 Ratio), indicating detectable antinuclear antibodies.
Clinical Correlation	No autoimmune activity detected via this assay.	Suggestive of systemic autoimmune disease (SLE, Sjögren’s, Scleroderma, etc.).
Antibody Specificity	Absent	Presence of specific autoantibodies (e.g., anti-dsDNA, anti-Sm, anti-SSA, anti-Scl-70).
Serum Proteins	Normal distribution	Hypergammaglobulinemia (often associated with chronic autoimmune stimulation).
Drug-Induced Markers	Absent	Positive anti-histone antibodies, suggesting drug-induced lupus syndrome.
Overlap Syndrome Indicators	Negative	Co-existence of multiple autoantibodies (e.g., anti-RNP and anti-Jo-1).
Infection-Related Transient ANA	Negative	Low-titer transient positivity due to active viral or bacterial infections.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for ANA BY ELISA?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, technologists, and phlebotomists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the testing process.
• Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control measures to ensure highly reproducible results.
• Professional Reporting: Our reports are detailed, clear, and structured to assist clinicians in making accurate diagnoses.
• Modern Diagnostic Approach: We utilize state-of-the-art ELISA platforms and automated systems for precise antibody detection.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, welcoming, and stress-free experience.
• Convenient Location: Easily accessible facilities across Lahore make it simple for patients to undergo diagnostic testing.
• Commitment to Accurate Diagnosis: We understand the impact of diagnostic accuracy on patient lives and strive for perfection in every test we perform.